Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.
Atallah E, Nussenzveig R, Yin CC, Bueso-Ramos C, Tam C, Manshouri T, Pierce S, Kantarjian H, Verstovsek S. Atallah E, et al. Leukemia. 2008 Jun;22(6):1295-8. doi: 10.1038/sj.leu.2405054. Epub 2007 Dec 6. Leukemia. 2008. PMID: 18059483 No abstract available.
Emerging drugs for myelofibrosis.
Atallah E, Verstovsek S. Atallah E, et al. Expert Opin Emerg Drugs. 2012 Dec;17(4):555-70. doi: 10.1517/14728214.2012.748748. Expert Opin Emerg Drugs. 2012. PMID: 23186315 Free PMC article. Review.
Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis.
Verstovsek S, Atallah E, Mascarenhas J, Sun H, Montgomery M, Gupta V, Mesa R, Gotlib J. Verstovsek S, et al. Among authors: atallah e. Leukemia. 2016 Jun;30(6):1413-5. doi: 10.1038/leu.2015.310. Epub 2015 Nov 3. Leukemia. 2016. PMID: 26526986 Free PMC article. Clinical Trial. No abstract available.
206 results